Clinical trial

Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2

NCT04604470

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-10-20

PhaseN/A

Study timeline

Study start (estimated)2020-10-20Date precision: day

Registry last updated2020-10-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC Stage IVunresolved

Lung Cancerunresolved

Non Small Cell Lung Cancerunresolved

Metastatic Cancerunresolved

Interventions

Decision toolOTHER

Sponsors & collaborators

Maastricht Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04604470 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.